Quantcast

Natural Antimicrobial Chemical Proven to Kill Clostridium Difficile Spores

March 2, 2011

A new, safe alternative antimicrobial formula to displace traditional highly-toxic sporicidal disinfectants could help reduce the growing number of hospital-acquired Clostridum difficile-related infections.

Farmington Hills, MI (Vocus/PRWEB) March 01, 2011

UrthTech, a Farmington Hills, Michigan based company, announced today that it found its patented Urthâ“¢ chemical technology is an effective antimicrobial agent against Clostridium difficile (C. diff) spores. Reports from ATS Labs in Eagan, Minnesota confirmed that two variants of Urthâ“¢ demonstrated a greater than 99.9999% (> 6.76 log10) reduction of C. diff spores (ATCC 700792) following a 10 minute exposure time when tested at room temperature (19.9°C).

The Urthâ“¢ technology (U.S. patent #7,754,766) is the intellectual property founded by UrthTech which powers the product they currently market as UrthPROâ“¢””a hospital-level disinfectant that is effective against mold, bacteria, fungi and the Influenza A viruses (including the H1N1 virus). UrthPROâ“¢ is the first of many products to spawn from the versatile applications for the Urthâ“¢ technology, which include an all-natural hand sanitizer effective against a wider range of germs than currently available (such as the H1N1 virus), all-natural antimicrobial hand soap, surface cleaner and disinfectants and a chemical sterilent among others.

“We’re excited to get the great news that this technology we’ve worked so hard on is getting positive results, especially with the Clostridium difficile superbug” said Robert George Jr. , president of UrthTech. “The major advantages we have with what we are calling UrthMEDâ“¢ is its compatibility with virtually any surface, its user friendly nature, and its impressive efficacy.”

UrthTech plans to further its testing of UrthMED̢Ң in the coming months, and expects to launch this breakthrough product some time in the next year.

This new development is an important advance in infection control products for places like hospitals, nursing homes and clinics. “We want to help control the severity of infection problems plaguing the healthcare industry. These issues don’t just affect the person contracting the illness, but are extremely costly for the healthcare industry and cause a trickle-down effect on the expense of providing medical coverage. People contract preventable illnesses every day and it’s in part due to the fact that safe and effective products are not available to help healthcare professionals disinfect potentially hazardous points of contact,” said George.

Recent studies have shown that a good cleaning regiment on hand-touch sites in healthcare facilities utilizing a disinfectant with sporicidal action can significantly reduce the occurrence of C.diff infections. Naturally, providing healthcare workers with a safer and more environmentally responsible solution to augment their cleaning regiment can have a compelling effect on workplace hygiene and worker safety; a combination that is sure to make UrthMED̢Ң a revolutionary product for the healthcare industry.

For more information about UrthTech or the Urth̢Ң technology, visit http://www.urthtech.com or contact the company at info(at)urthtech(dot)com or (800) 949-URTH (8784).

About UrthTech, LLC.

UrthTech is the leading developer of environmentally responsible antimicrobial products and specialty edible oils. With an emphasis on innovation, the company’s research focus is on healthful solutions to the world’s most pressing sanitary and nutritional concerns. Its proprietary Urthâ“¢ technology is utilized in such product lines as UrthPROâ“¢, which is used primarily for water damage restoration, mold remediation and disinfection of commercial facilities. UrthTech is privately held with headquarters in Farmington Hills, MI. For more information, please visit http://www.urthtech.com or http://www.urthpro.com.

# # #

For the original version on PRWeb visit: http://www.prweb.com/releases/prweburthmed/cdiff/prweb8166842.htm


Source: prweb



comments powered by Disqus